• Users Online: 125
  • Print this page
  • Email this page
Year : 2021  |  Volume : 4  |  Issue : 2  |  Page : 69-74

Epidemiology and management of mucormycosis in India – Pre- and Post-COVID-19

Department of Microbiology, Apollo Hospitals, Chennai, Tamil Nadu, India

Correspondence Address:
Nandini Sethuraman
Department of Microbiology, Apollo Hospitals, Greams Road, Chennai, Tamil Nadu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/japt.japt_42_21

Rights and Permissions

Mucormycosis is a spectrum of highly invasive infections caused by filamentous fungi belonging to the order Mucorales. Typically known as a disease of the immunocompromised and uncontrolled diabetic host, the COVID-19 pandemic uncovered new and hitherto unknown facets of this disease. A thorough knowledge of its epidemiology, methods of diagnosis, and treatment options available is important to manage the carnage this disease has unveiled upon us in current times. This review provides an updated understanding of the existing problem of mucormycosis in India and the added burden due to the COVID-19 pandemic and provides an insight into the challenges involved in making a diagnosis and managing these debilitating infections.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded25    
    Comments [Add]    

Recommend this journal